The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Less words is just a slogan.
'It works'.
Sometimes it's a little more nuanced.
HCI will have mandated it as part of the CLN negotiations.?
You think so Beinthelead?
They dictated to Dr Smith what he had to do to get his hands on their money did they?
Really? Or just spouting tosh in an authoritive manner?
Have a theory by all means, even a ludicrous one, but don't state it as fact perhaps.
HCI will have mandated it as part of the CLN negotiations.?
You think so Beinthelead?
They dictated to Dr Smith what he had to do to get his hands on their money did they?
Really? Or just spouting tosh in an authoritive manner?
Have a theory by all means, even a ludicrous one, but don't state it as fact perhaps.
The World turns, Avacta continues to dose patients (slowly) and at some point the 2 week arm will start to be able to offer clues as to what 2 weekly dosing might be able achieve in those tumours most likely to respond.
At this point the SP should pick up and build into Phase 2?
A couple of Heights hand outs before then, hopefully no more than 3?
The rest is noise. Funny how you get to see how much of the 'discussion' is just personality cults and gangs.
Read the RNS?
". A land use agreement is now being prepared which, once signed, will allow 2024 operations to go ahead commencing with completion operations on the Heron 1 well."
Land access was agreed but the land use agreement needs to be prepared ie drafted, circulated, amended as necessary, re-circulated for approval then minuted as an item at the next Council meeting for formal/legal sign off?
Might happen by the AGM but if not I'm sure there'll be news of how it's progressing and upcoming plans for the Heron field.
Oh look Prof, now that's what I call a balanced post!
You said something about not being as stupid as they looked?
Height's loan was not dependent of a 'business case' model whereby the proposed Diagnostic income was used to underwrite the loan.
It was dependent on Heights judging that Avacta weren't going to go bust before the loan had been repaid.
Anyway there's no point disagreeing. We couldn't agree if white was white or black was black.
If 'quickly' means 6 to 12 months then I'd have to disagree Roxy.
12 months time.
Heron wells flowing and filling Petro Matad's coffers nicely.
Further Heron wells/field development planned and paid for out of income for 2025.
New blocks assigned and being worked up/seismics for frontier exploration, other drills nearer to home already identified and partially de-risked etc.
Details of SunSteppe renewable plans etc.
Lots of news, lots of developments, lots of RNSs.
Care to put a Market Cap/Share Price on that? Minimal if any further raises/dilution required from here on in.
FAP on chirrhotic liver cells and arthritic joints?
Check you 'facts'?
The 'Potash' reference I stand by. There was nothing wrong with Sirius Mineral's asset: Truly potentially World class and still is.
They just couldn't raise the funds to develop the asset fully to get it to Market before they went bust. No one would lend them the money.
Remember the 50p raise at half the then prevailing Share Price, why was that then?
So when they sell the income generating Diagnostic companies Heights will be entitled to say that the contract has been broken and demand repayment.
Is that what you're saying?
So long as they judge that the company won't go bust before they have been able to repay the loan they'll sign the paper.
But you carry on thinking what you want and I'll carry on thinking what I want.
We don't usually agree on much.
Still well ahead of schedule are they by the way?
They'd have lent the 50 million regardless.
It's paid back in shares at a discount to the prevailing share price, Avacta's cash generation had nothing to do with it.
They don't care if the company can't afford it in real terms so long as they continue to get more and more shares issued at an ever decreasing share price.
That's why companies get into trouble with these sort of deals. They probably see it as a stop gap funding measure whilst the share price increases with the positive clinical data and expected 'inflection points'.
Then you find yourself with the 2 weeks trial falling steadily behind schedule(Q4 2023?) and ongoing escalating costs with a share price less than half it was when the deal was struck.
All of a sudden it doesn't look so clever.
I'm sure there'll be pullback too but the first RNS will effectively lead to a number of other significant RNSs in sort order.
Petro Matad should have been working on contracts, funding etc to make a fast start on the Heron makeover, this followed shortly thereafter by flow rates and news of other planned wells for the Heron Field will keep ratcheting up the SP and Investor expectations.
With the likely amounts involved and the current very low Market Cap of the company relative to what the Heron Field is capable of delivering it's all just so much fluff on the wind.
It's all about the land permit.
Of course sometimes things change very fast indeed.
Usually at 7am.
And on these occasions there's no time to review your thoughts and change your tactics.
You're discounting the possibility of another Petrovis 'soft loan' then Prof?
In any event a fundraise to expedite/enable the Heron Field development to produce/sell oil is a completely different matter to just funding ongoing overheads and expenses.
It still all comes down the Land Permit with or without the need for a raise.
I wonder if anything was said at today's meeting?
It's good to focus on the specific matters in hand rather than rather generic statements based on pre conceived notions and prejudices.
Things change, sometimes slowly, but they change and when they do you need to review your thoughts on the matter.
I'm defining 'investors' as people who make money by investing in stocks.
ie picking stocks that end up being worth more over time than when they bought them.
Disclaimer: I'm well aware that at some i'll defined time point in the future this might apply to Avacta but knowing the likely time lines for the ongoing AVA6000 trial I'm not expecting to caught out in the next 3-6 months.
As I said earlier Avacta might turn out to be a very good company and a very good investment in the longer term.
Groot's right, be happy you're invested.
That's an order.
Any idea on timeframes for 'extremely likely to generate excellent returns'?
Before or after the next couple of Height's conversions?
Just asking on behalf of actual investors.
This a quality company with quality top management and clinical teams including the CEO.
They're doing an excellent job of bringing some hopefully excellent drugs to market.
So far AVA6000 appears to be following the plan very nicely thank you very much.
If investors hadn't realised the need for long expensive drug trials prior to a hopeful good clinical trial results and a share price re-rate then that's not Dr Smith's fault.
Invest and wait patiently or wait patiently and then invest.
There's always the possibility of problems and ultimately it might not be everything investors hope that it will be. Time will tell.
A don't think a take over is likely until there's more data.
Low numbers of patients with a variety of cancers and previous treatment regimes don't lend themselves to data analysis.
It amounts to a whole load of not a lot.
The data to date is encouraging but that's all that can be said at this point.
Numbers, numbers and more numbers is what they'll want.
It all takes time, and money.